Drugs / 18F-FDB
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00771381 | Nov 2008 → Feb 2019 | breast neoplasm | AHS Cancer Control Alberta | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 18F-FDB | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00771381 ↗ |
| Known as | FluGlucoScan Injection | “FluGlucoScan Injection (18F-FDB) PET scan” NCT00771381 ↗ |
| Modality | Diagnostic / imaging agent | “PET scan” NCT00771381 ↗ |